|
Detailed information for selected cell line:
| Cell Line: |
UCLA 7; disease-specific mutation |
| NIH Registration Number: |
0143
|
| NIH Approval Number: |
NIHhESC-12-0143
|
| Available for Distribution: |
Other
- possibly in future: contact speckman@mednet.ucla.edu
|
| Provider Restrictions: |
hESC recipients must provide documentation of of ESCRO, IRB, or equivalent ethical review for the reseach planned with the requested line.
|
| NIH Restrictions: |
(No Additional Restrictions)
|
| Additional Information: |
UCLA 7 (47, XX+13) was Karyotyped at passage 7 after derivation. Cytogenic analysis of the resulting hESC line was performed on twenty G-banded metaphase cells and all twenty cells demonstrated trisomy 13. No other karyotypic abnormality was identified. Trisomy 13 is a genetic disorder also referred to as Patau syndrome.
|
| Submitting Organization: |
University of California, Los Angeles |
| Provider Name: |
Steven Peckman
|
| Provider Phone: |
310-794-4919
|
| Provider Email: |
speckman@mednet.ucla.edu
|
| Provider URL: |
www.stemcell.ucla.edu
|
| Approval Date: |
01/12/2012 |
View All Lines Eligible for Use
Go to NIH Form 2890 Login Page
Go to NIH Stem Cell Information Page
| 
Social Media Links